ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD)ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD)ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD)

ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD)

No trades
See on Supercharts

Price target

0.210.000.00%
The 1 analyst offering 1 year price forecasts for 0QNV have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to 0QNV in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


0QNV EPS for the last quarter is −0.02 CHF despite the estimation of −0.01 CHF. In the next quarter EPS is expected to reach −0.01 CHF. Track more of ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) financials and stay on top of what is up with the company.
In the next quarter ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) revenue is expected to reach ‪100.00 K‬ CHF. Check out ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) revenue and earnings and make informed decisions.
According to analysts, 0QNV price target is 0.21 CHF with a max estimate of 0.21 CHF and a min estimate of 0.21 CHF. Check if this forecast comes true in a year, meanwhile watch ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) stock price chart and keep track of the current situation with 0QNV news and stock market news.